1
|
Sánchez-Carro Y, de la Torre-Luque A, Díaz-Marsá M, Aguayo-Estremera R, Andreo-Jover J, Ayad-Ahmed W, Bobes J, Bobes-Bascarán T, Bravo-Ortiz MF, Canal-Rivero M, Cebrià AI, Crespo-Facorro B, Elices M, Fernández-Rodrigues V, Lopez-Peña P, Grande I, Palao-Tarrero Á, Pemau A, Roberto N, Ruiz-Veguilla M, Pérez-Solà V. Psychiatric profiles in suicidal attempters: Relationships with suicide behaviour features. Span J Psychiatry Ment Health 2024:S2950-2853(24)00011-5. [PMID: 38331321 DOI: 10.1016/j.sjpmh.2024.01.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/13/2023] [Revised: 01/17/2024] [Accepted: 01/22/2024] [Indexed: 02/10/2024]
Abstract
BACKGROUND Suicide constitutes a major health concern worldwide, being a significant contributor of death, globally. The diagnosis of a mental disorder has been extensively linked to the varying forms of suicidal ideation and behaviour. The aim of our study was to identify the varying diagnostic profiles in a sample of suicide attempters. METHODS A sample of 683 adults (71.3% females, 40.10±15.74 years) admitted at a hospital emergency department due to a suicide attempt was recruited. Latent class analysis was used to identify diagnostic profiles and logistic regression to study the relationship between comorbidity profile membership and sociodemographic and clinical variables. RESULTS Two comorbidity profiles were identified (Class I: low comorbidity class, 71.3% of attempters; Class II: high comorbidity class, 28.7% of attempters). Class I members were featured by the diagnosis of depression and general anxiety disorder, and low comorbidity; by contrast, the high comorbidity profile was characterized by a higher probability of presenting two or more coexisting psychiatric disorders. Class II included more females, younger, with more depressive symptoms and with higher impulsivity levels. Moreover, Class II members showed more severe suicidal ideation, higher number of suicide behaviours and a greater number of previous suicide attempts (p<.01, for all the outcomes), compared to Class I members. CONCLUSIONS Psychiatric profiles may be considered for treatment provision and personalized psychiatric treatment in suicidal attempters as well as tackle suicide risk.
Collapse
Affiliation(s)
- Yolanda Sánchez-Carro
- Department of Psychiatry, Universidad Autónoma de Madrid, Madrid, Spain; CIBERSAM ISCIII, Madrid, Spain
| | | | - Marina Díaz-Marsá
- CIBERSAM ISCIII, Madrid, Spain; Universidad Complutense de Madrid, Madrid, Spain; Hospital Clinico San Carlos, Madrid, Spain.
| | | | - Jorge Andreo-Jover
- Department of Psychiatry, Universidad Autónoma de Madrid, Madrid, Spain; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
| | | | | | - Teresa Bobes-Bascarán
- CIBERSAM ISCIII, Madrid, Spain; Universidad de Oviedo, Spain; Instituto de Investigación Sanitaria del Principado de Asturias, Spain; Instituto de Neurocias del Principado de Asturias, Spain
| | - María Fé Bravo-Ortiz
- Department of Psychiatry, Universidad Autónoma de Madrid, Madrid, Spain; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital, Madrid, Spain
| | - Manuel Canal-Rivero
- CIBERSAM ISCIII, Madrid, Spain; UGC-Salud Mental de Hospital Virgen del Rocío/IBIS Sevilla, Spain; Universidad de Sevilla, Spain
| | | | - Benedicto Crespo-Facorro
- CIBERSAM ISCIII, Madrid, Spain; UGC-Salud Mental de Hospital Virgen del Rocío/IBIS Sevilla, Spain; Universidad de Sevilla, Spain
| | - Matilde Elices
- Institut Hospital del Mar d'Investigacions Mediques (IMIM), Barcelona, Spain
| | | | - Purificacion Lopez-Peña
- CIBERSAM ISCIII, Madrid, Spain; Department Psychiatry, Hospital Universitario Alava, Bioaraba, UPV/EHU, Osakidetza, Spain
| | - Iría Grande
- CIBERSAM ISCIII, Madrid, Spain; Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain; Bipolar and Depressive Disorders Unit, Hospìtal Clinic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Institute of Neurosciences (UBNeuro), Spain
| | - Ángela Palao-Tarrero
- Department of Psychiatry, Universidad Autónoma de Madrid, Madrid, Spain; Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain; Department of Psychiatry, Clinical Psychology and Mental Health, La Paz University Hospital, Madrid, Spain
| | - Andrés Pemau
- Universidad Complutense de Madrid, Madrid, Spain
| | - Natalia Roberto
- CIBERSAM ISCIII, Madrid, Spain; Departament de Medicina, Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain; Bipolar and Depressive Disorders Unit, Hospìtal Clinic de Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Institute of Neurosciences (UBNeuro), Spain
| | - Miguel Ruiz-Veguilla
- CIBERSAM ISCIII, Madrid, Spain; UGC-Salud Mental de Hospital Virgen del Rocío/IBIS Sevilla, Spain; Universidad de Sevilla, Spain
| | - Víctor Pérez-Solà
- CIBERSAM ISCIII, Madrid, Spain; Institut Hospital del Mar d'Investigacions Mediques (IMIM), Barcelona, Spain
| |
Collapse
|
2
|
Pina-Camacho L, Martinez K, Diaz-Caneja CM, Mezquida G, Cuesta MJ, Moreno C, Amoretti S, González-Pinto A, Arango C, Vieta E, Castro-Fornieles J, Lobo A, Fraguas D, Bernardo M, Janssen J, Parellada M, Madero S, Gómez-Ramiro M, Rodriguez-Toscano E, Santonja J, Zorrilla I, González-Ortega I, Fayed N, Santabárbara J, Berge D, Toll A, Nacher J, Martí GG, Sague-Vilavella M, Sanchez-Moreno J, de la Serna E, Baeza I, Saiz-Masvidal C, Contreras F, González-Blanco L, Bobes-Bascarán T, Dompablo M, Rodriguez-Jimenez R, Usall J, Butjosa A, Pomarol-Clotet E, Sarró S. Cortical thinning over two years after first-episode psychosis depends on age of onset. Schizophr 2022; 8:20. [PMID: 35277520 PMCID: PMC8917180 DOI: 10.1038/s41537-021-00196-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/27/2021] [Accepted: 11/10/2021] [Indexed: 11/09/2022]
Abstract
AbstractFirst-episode psychosis (FEP) patients show structural brain abnormalities at the first episode. Whether the cortical changes that follow a FEP are progressive and whether age at onset modulates these changes remains unclear. This is a multicenter MRI study in a deeply phenotyped sample of 74 FEP patients with a wide age range at onset (15–35 years) and 64 neurotypical healthy controls (HC). All participants underwent two MRI scans with a 2-year follow-up interval. We computed the longitudinal percentage of change (PC) for cortical thickness (CT), surface area (CSA) and volume (CV) for frontal, temporal, parietal and occipital lobes. We used general linear models to assess group differences in PC as a function of age at FEP. We conducted post-hoc analyses for metrics where PC differed as a function of age at onset. We found a significant age-by-diagnosis interaction effect for PC of temporal lobe CT (d = 0.54; p = 002). In a post-hoc-analysis, adolescent-onset (≤19 y) FEP showed more severe longitudinal cortical thinning in the temporal lobe than adolescent HC. We did not find this difference in adult-onset FEP compared to adult HC. Our study suggests that, in individuals with psychosis, CT changes that follow the FEP are dependent on the age at first episode, with those with an earlier onset showing more pronounced cortical thinning in the temporal lobe.
Collapse
|
3
|
Martínez-Cao C, García-Álvarez L, Bobes-Bascarán T, de la Fuente-Tomás L, Fernández-Egea E, Velasco Á, González-Blanco L, Zurrón-Madera P, Fonseca-Pedrero E, Sáiz-Martínez PA, García-Portilla MP, Bobes J. Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia. Rev Psiquiatr Salud Ment (Engl Ed) 2022; 15:22-28. [PMID: 35256069 DOI: 10.1016/j.rpsmen.2020.04.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2019] [Accepted: 04/16/2020] [Indexed: 06/14/2023]
Abstract
INTRODUCTION Apathy is a negative symptom of schizophrenia and is associated with poor real world functioning. Therefore, it is important to have validated psychometric instruments to assess this symptom. This is the first study to validate the Spanish adaptation of the self-rated version of the Apathy Assessment Scale (AES-S) in patients with schizophrenia. MATERIALS AND METHODS Naturalistic, cross-sectional, validation study in 104 patients with schizophrenia evaluated using the following scales: Clinical Global Impression-Severity (CGI-S), Personal and Social Performance (PSP), Clinical Assessment Interview for Negative Symptoms (CAINS), Self-report of Negative Symptoms (SNS), Motivation and Pleasure Scale-Self-Report (MAP-SR), Calgary Depression Scale for Schizophrenia (CDSS), and Apathy Evaluation Scale-self-rated version (AES-S). RESULTS Reliability: Internal consistency (Cronbach's alpha) was 0.908. Convergent validity: The Pearson correlation coefficient between AES-S and CAINS-MAP total scores was -0.483 (p<0.001). For SNS, total and avolition subscale scores were -0.803 and -0.639 (p<0.001), respectively. With the MAP-SR, the correlation coefficient was -0.727 (p<0.001). Divergent validity: The Pearson correlation coefficient between AES-S and PSP total scores was 0.504 (p<0.001). Furthermore, with the CDSS, the correlation coefficient was -0.431 (p<0.001). Discriminant validity: The AES-S discriminated between different levels of illness severity according to CGI-S scores. Factor analysis: A three-component solution explained 57.32% of the variance. Pearson correlations between coefficients were 1-2=0.265, 1-3=0.464, and 2-3=0.060. CONCLUSION The Spanish AES-S is a reliable and valid instrument for assessing apathy in Spanish patients with schizophrenia. It seems to be appropriate for use in everyday clinical practice as a means of monitoring apathy in these patients.
Collapse
Affiliation(s)
| | | | | | | | | | - Ángela Velasco
- Dpto. Psiquiatría, CIBERSAM, Universidad de Oviedo, Oviedo, Spain
| | | | | | | | | | | | - Julio Bobes
- Dpto. Psiquiatría, CIBERSAM, ISPA, Universidad de Oviedo, Oviedo, Spain
| |
Collapse
|
4
|
García-Álvarez L, Martínez-Cao C, Bobes-Bascarán T, Portilla A, Courtet P, de la Fuente-Tomás L, Velasco Á, González-Blanco L, Zurrón-Madera P, Fonseca-Pedrero E, Sáiz PA, García-Portilla MP, Bobes J. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia. Rev Psiquiatr Salud Ment (Engl Ed) 2022; 15:14-21. [PMID: 35256068 DOI: 10.1016/j.rpsmen.2022.01.005] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2019] [Accepted: 04/28/2020] [Indexed: 06/14/2023]
Abstract
INTRODUCTION Negative symptoms can be grouped into five domains: apathy/avolition, anhedonia, asociality, alogia, and affective flattening. There are few validate self-rated measures that assess these five dimensions. Therefore, this study aimed to validate the Self-Evaluation of Negative Symptoms (SNS) in Spanish patients with schizophrenia. MATERIAL AND METHODS Cross-sectional, validation study in 104 outpatients with schizophrenia evaluated using the Spanish version of the following scales: Clinical Assessment Interview for Negative Symptoms (CAINS), Positive and Negative Syndrome Scale (PANSS), Clinical Global Impression Scale for Schizophrenia (CGI-SCH), Personal and Social Performance (PSP), Motivation and Pleasure Scale - Self-Report (MAP-SR), 36-item Short-Form Health Survey (SF-36) and the Self-Evaluation of Negative Symptoms (SNS). RESULTS RELIABILITY Internal consistency (Cronbach's alpha) was 0.915. Convergent validity: The Pearson correlation coefficient between MAP-SR and SNS Total scores was 0.660 (p<0.001). For PANSS-N, the correlation was 0.437 (p<0.005) and with the CAINS-Total was 0.478 (p<0.005). Divergent validity: The Pearson correlation coefficient between SNS and PSP was r=-0.372 (p≤0.001), and with SF-36 Physical and Mental Summary Component scores were r=-0.213 (p=0.066) and r=-0.144 (p=0.219), respectively. Discriminant validity: SNS Total scores were significantly statistically different according to the severity of the negative symptomatology rated by the CGI-SCH negative scale (p<0.001). CONCLUSION The SNS is a reliable and valid instrument to self-rate the five domains of negative symptoms in patients with schizophrenia and seems to be appropriate for use in everyday clinical practice as a complementary measure to the evaluation performed by the clinician.
Collapse
Affiliation(s)
- Leticia García-Álvarez
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain
| | - Clara Martínez-Cao
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain
| | - Teresa Bobes-Bascarán
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain
| | - Almudena Portilla
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain
| | | | - Lorena de la Fuente-Tomás
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain
| | - Ángela Velasco
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain
| | - Leticia González-Blanco
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain
| | - Paula Zurrón-Madera
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain
| | - Eduardo Fonseca-Pedrero
- Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Departamento Ciencias de la Educación, Universidad de la Rioja, Longroño, Spain
| | - Pilar A Sáiz
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain
| | - María Paz García-Portilla
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain.
| | - Julio Bobes
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain
| |
Collapse
|
5
|
Cervera-Martínez J, Atienza-Carbonell B, Mota JC, Bobes-Bascarán T, Crespo-Facorro B, Esteban C, García-Portilla MP, Gomes-da-Costa S, González-Pinto A, Jaén-Moreno MJ, Sarramea F, Vieta E, Zorrilla I, Tabarés-Seisdedos R, Kapczinski F, De Boni RB, Balanzá-Martínez V. Lifestyle changes and mental health during the COVID-19 pandemic: A repeated, cross-sectional web survey. J Affect Disord 2021; 295:173-182. [PMID: 34469856 PMCID: PMC8418875 DOI: 10.1016/j.jad.2021.08.020] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/30/2021] [Revised: 08/06/2021] [Accepted: 08/18/2021] [Indexed: 12/01/2022]
Abstract
BACKGROUND This study aimed to compare self-reported changes on lifestyle behaviors during two phases of the COVID-19 pandemic in Spain, and to evaluate clinical and sociodemographic factors associated with lifestyles. METHODS Two cross-sectional web surveys were conducted during lockdown (April 15-May 15, 2020) and seven months later (November 16-December 16, 2020). Lifestyle behaviors were self-reported by a multidimensional scale (SMILE-C). Two separate samples of respondents were analyzed. A multivariate regression model was performed to evaluate the association of SMILE-C scores with demographic and clinical variables. RESULTS The sample comprised, 3412 participants from the first survey (S1) and in the S1 and 3635 from the second (S2). SMILE-C score decreased across surveys (p < 0.001). The rates of positive screenings for depression and anxiety were similar between the surveys, whereas those for alcohol abuse decreased (p < 0.001). Most participants in S2 reported that their lifestyle had not changed compared to those before the pandemic. Variables independently associated with an unhealthier lifestyle were working as an essential worker, lower educational level, previous mental disease, worse self-rated health, totally/moderate changes on diet, sleep or social support, as well as positive screenings for alcohol abuse, anxiety and depression. LIMITATIONS The cross-sectional design and recruitment by non-probabilistic methods limit inferring causality and the external validity of the results. CONCLUSIONS Overall lifestyle worsened seven months after the lockdown in Spain. Several demographic and clinical factors were associated with lifestyle scores. The contribution of common mental disorders to unhealthier lifestyles should be considered in order to prevent the negative impact of the pandemic.
Collapse
Affiliation(s)
- Jose Cervera-Martínez
- Hospital de Denia-Marina Salud, Alicante, Spain,Department of Medicine, University of Valencia, Valencia, Spain
| | | | - Jurema C. Mota
- Institute of Scientific and Technological Communication and Information in Health (ICICT), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil
| | - Teresa Bobes-Bascarán
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain,Servicio de Salud del Principado de Asturias (SESPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain,Department of Psychology, University of Oviedo, Oviedo, Spain
| | - Benedicto Crespo-Facorro
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain,Hospital Universitario Virgen del Rocío, IBIS, Seville, Spain,University of Sevilla, Seville, Spain
| | | | - María Paz García-Portilla
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain,Servicio de Salud del Principado de Asturias (SESPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain,Department of Psychiatry, School of Medicine, University of Oviedo, Oviedo, Spain
| | - Susana Gomes-da-Costa
- Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, Barcelona, Catalonia, Spain
| | - Ana González-Pinto
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain,Hospital Universitario de Alava. BIOARABA, UPV-EHU, Vitoria, Spain
| | - M. José Jaén-Moreno
- Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain,Departamento de Ciencias Morfológicas y Sociosanitarias, Universidad de Córdoba, Córdoba, Spain
| | - Fernando Sarramea
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain,Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain,Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain
| | - Eduard Vieta
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain,Hospital Clinic, Institute of Neuroscience, University of Barcelona, IDIBAPS, Barcelona, Catalonia, Spain
| | - Iñaki Zorrilla
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain,Hospital Universitario de Alava. BIOARABA, UPV-EHU, Vitoria, Spain
| | - Rafael Tabarés-Seisdedos
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain,Department of Medicine, Teaching Unit of Psychiatry and Psychological Medicine, University of Valencia, Blasco Ibáñez, 15, Valencia 46010, Spain
| | - Flavio Kapczinski
- Departament of Psychiatry and Behavioral Neurosciences, McMaster University, Mood Disorders Program, St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada,Department of Psychiatry, Universidade Federal do Rio Grande do Sul (UFRGS), Instituto Nacional de Ciência e Tecnologia Translacional em Medicina (INCT-TM), Porto Alegre, RS, Brazil
| | - Raquel B. De Boni
- Institute of Scientific and Technological Communication and Information in Health (ICICT), Oswaldo Cruz Foundation (FIOCRUZ), Rio de Janeiro, Brazil
| | - Vicent Balanzá-Martínez
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain; Department of Medicine, Teaching Unit of Psychiatry and Psychological Medicine, University of Valencia, Blasco Ibáñez, 15, Valencia 46010, Spain.
| |
Collapse
|
6
|
García-Portilla P, de la Fuente Tomás L, Bobes-Bascarán T, Jiménez Treviño L, Zurrón Madera P, Suárez Álvarez M, Menéndez Miranda I, García Álvarez L, Sáiz Martínez PA, Bobes J. Are older adults also at higher psychological risk from COVID-19? Aging Ment Health 2021; 25:1297-1304. [PMID: 32870024 DOI: 10.1080/13607863.2020.1805723] [Citation(s) in RCA: 52] [Impact Index Per Article: 17.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Abstract
OBJECTIVE Given the lack of information on the psychological impact of COVID-19 on people aged ≥60, we aimed to describe their psychological responses to this pandemic and lockdown situation and compare them with those under 60 years of age. METHODS Secondary analysis of a larger online cross-sectional study designed to determine the psychological impact of the COVID-19 pandemic and lockdown across Spain. We analyzed a total of 1690 respondents aged ≥60 years and compared them with 13,363 respondents under 60 years of age. We employed the Depression, Anxiety, and Stress Scale and the Impact of Event Scale to evaluate psychological responses. RESULTS In all, 52.6% of women and 34.3% of men were found to be probable cases of any emotional distress (p < 0.001). In both sexes, the most common psychological response was avoidance behavior (34.7% and 23.8%, respectively), followed by depression (28.5 and 14.2%). Older women and men were considered probable cases of any emotional distress less often than younger ones (women: 52.6% vs. 72.3%, p < 0.001; men: 34.3% vs. 50.6%, p < 0.001). Finally, the results of the binary logistic regression showed that only depressive and stress responses are psychological factors associated with age group [age ≥ 60 years, O.R. = 0.617 (95% CI = 0.501 - 0.759) and 0.437 (95% CI = 0.334 - 0.573), respectively]. CONCLUSION Contrary to our hypothesis and despite the high percentage of emotional distress we found in older adults, especially women, they are actually at lower risk of developing depressive and stress consequences from COVID-19 and lockdown than those under 60 years of age. That said, we believe our results highlight the need for expert guidance in this age group, especially older women living alone.
Collapse
Affiliation(s)
- Paz García-Portilla
- Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.,Instituto de Investigación Sanitaria Del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias Del Principado de Asturias (INEUROPA), Oviedo, Spain.,Servicio de Salud Del Principado de Asturias (SESPA), Oviedo, Spain
| | - Lorena de la Fuente Tomás
- Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.,Instituto de Investigación Sanitaria Del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias Del Principado de Asturias (INEUROPA), Oviedo, Spain
| | - Teresa Bobes-Bascarán
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.,Instituto de Investigación Sanitaria Del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias Del Principado de Asturias (INEUROPA), Oviedo, Spain.,Servicio de Salud Del Principado de Asturias (SESPA), Oviedo, Spain.,Department of Psychology, Universidad de Oviedo, Oviedo, Spain
| | - Luis Jiménez Treviño
- Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.,Instituto de Investigación Sanitaria Del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias Del Principado de Asturias (INEUROPA), Oviedo, Spain.,Servicio de Salud Del Principado de Asturias (SESPA), Oviedo, Spain
| | - Paula Zurrón Madera
- Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.,Instituto de Investigación Sanitaria Del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias Del Principado de Asturias (INEUROPA), Oviedo, Spain.,Servicio de Salud Del Principado de Asturias (SESPA), Oviedo, Spain
| | | | - Isabel Menéndez Miranda
- Instituto de Investigación Sanitaria Del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias Del Principado de Asturias (INEUROPA), Oviedo, Spain.,Servicio de Salud Del Principado de Asturias (SESPA), Oviedo, Spain
| | - Leticia García Álvarez
- Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.,Instituto de Investigación Sanitaria Del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias Del Principado de Asturias (INEUROPA), Oviedo, Spain.,Department of Psychology, Universidad de Oviedo, Oviedo, Spain
| | - Pilar A Sáiz Martínez
- Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.,Instituto de Investigación Sanitaria Del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias Del Principado de Asturias (INEUROPA), Oviedo, Spain.,Servicio de Salud Del Principado de Asturias (SESPA), Oviedo, Spain
| | - Julio Bobes
- Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Oviedo, Spain.,Instituto de Investigación Sanitaria Del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias Del Principado de Asturias (INEUROPA), Oviedo, Spain.,Servicio de Salud Del Principado de Asturias (SESPA), Oviedo, Spain
| |
Collapse
|
7
|
García-Portilla MP, García-Álvarez L, González-Blanco L, Dal Santo F, Bobes-Bascarán T, Martínez-Cao C, García-Fernández A, Sáiz PA, Bobes J. Real-World Functioning in Patients With Schizophrenia: Beyond Negative and Cognitive Symptoms. Front Psychiatry 2021; 12:700747. [PMID: 34434128 PMCID: PMC8381019 DOI: 10.3389/fpsyt.2021.700747] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/26/2021] [Accepted: 07/15/2021] [Indexed: 11/20/2022] Open
Abstract
Introduction: Interest in the idea of recovery for certain patients with schizophrenia has been growing over the last decade. Improving symptomatology and functioning is crucial for achieving this. Our study aims to identify those factors that substantially contribute to real-world functioning in these patients. Methods: We carried out a cross-sectional study in stable outpatients with schizophrenia on maintenance antipsychotic monotherapy. Patients: We studied 144 outpatients with schizophrenia (DSM-IV-TR criteria) meeting the following criteria: (1) 18-65 years of age; (2) being clinically stable for at least the previous three months; (3) on maintenance antipsychotic monotherapy (prescriptions ≤ 10 mg olanzapine, ≤200 mg quetiapine, or ≤100 mg levomepromazine as hypnotics were also allowed); and (4) written informed consent. Assessment: We collected information on demographic and clinical variables by using an ad hoc questionnaire. For psychopathology, we employed the Spanish versions of the following psychometric instruments: the Positive and Negative Syndrome Scale (PANSS), the Brief Negative Symptom Scale (BNSS-Sp), and the Calgary Depression Scale (CDS). In addition, cognitive domains were assessed using the Verbal Fluency Test (VFT), the Digit Symbol Substitution Test (DSST), and the Trail Making Test, parts A and B (TMT-A and TMT-B). Finally, we employed the Spanish versions of the University of California San Diego Performance-based Skills Assessment (Sp-UPSA) and the Personal and Social Performance (PSP) for assessing functional capacity and real-world functioning, respectively. Statistical analysis: A forward stepwise regression was conducted by entering those variables significantly associated with PSP total score into the univariate analyses (Student's t-test, ANOVA with Duncan's post-hoc test, or bivariate Pearson correlation). Results: A total of 144 patients; mean age 40 years, 64% males, mean length of illness 12.4 years, PSP total score 54.3. The final model was a significant predictor of real-world functioning [F (7, 131) = 36.371, p < 0.001] and explained 66.0% of the variance. Variables retained in the model: BNSS-Sp abulia, asociality, and blunted affect, PANSS general psychopathology, Sp-UPSA transportation, TMT-B, and heart rate. Conclusion: Our model will contribute to a more efficient and personalized daily clinical practice by assigning specific interventions to each patient based on specific impaired factors in order to improve functioning.
Collapse
Affiliation(s)
- María Paz García-Portilla
- Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.,Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain
| | - Leticia García-Álvarez
- Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain.,Department of Psychology, Universidad de Oviedo, Oviedo, Spain
| | - Leticia González-Blanco
- Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.,Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain
| | - Francesco Dal Santo
- Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.,Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain
| | - Teresa Bobes-Bascarán
- Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain.,Department of Psychology, Universidad de Oviedo, Oviedo, Spain
| | - Clara Martínez-Cao
- Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain
| | - Ainoa García-Fernández
- Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain
| | - Pilar A Sáiz
- Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.,Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain
| | - Julio Bobes
- Servicio de Salud del Principado de Asturias (SESPA), Oviedo, Spain.,Department of Psychiatry, Universidad de Oviedo, Oviedo, Spain.,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA), Oviedo, Spain
| |
Collapse
|
8
|
Bobes-Bascarán T, Sáiz PA, Velasco A, Martínez-Cao C, Pedrosa C, Portilla A, de la Fuente-Tomas L, García-Alvarez L, García-Portilla MP, Bobes J. Early Psychological Correlates Associated With COVID-19 in A Spanish Older Adult Sample. Am J Geriatr Psychiatry 2020; 28:1287-1298. [PMID: 32951996 PMCID: PMC7476442 DOI: 10.1016/j.jagp.2020.09.005] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/27/2020] [Revised: 09/01/2020] [Accepted: 09/02/2020] [Indexed: 01/10/2023]
Abstract
OBJECTIVE Main aims of the study are to examine the early psychological correlates associated with the COVID-19 pandemic and lockdown on the mental health of a Spanish older adult sample and to analyze the influence of past mental disorder (PMD) and current mental disorder (CMD) on those correlates. METHODS Cross-sectional study based on an online snowball recruiting questionnaire. Psychological correlates assessed with the Depression, Anxiety, and Stress Scale (DASS-21) and Impact of Event Scale (IES). Binary and multinomial logistic regression models were used to identify risk and protective factors. RESULTS Final sample included 2,194 individuals aged 60 years or more (mean age [SD]: 65.62 [5.05]; females: 1,198 [54.6%]). There were 342 (15.6%) individuals who reported a PMD and 162 (7.4%) who reported a CMD. Avoidant (32.1%) and depressive (25.6%) styles were the most prevalent, regardless of mental health status. Main risk factors for negative affectivity were female gender and history CMD or PMD. However, job stability and the ability to enjoy free time were generally associated with better outcomes. No differences were found in psychological correlates between those with no lifetime history of mental disorder versus PMD on the DASS-21 or IES. However, CMD was associated with higher anxiety scores on the DASS-21 (odds ratio: 1.838, p < .001). CONCLUSION Regardless of mental status, avoidant and depressive styles were the most prevalent in this older adult sample. Main protective factor in all subgroups was the ability to enjoy free time, whereas the main risk factors were being female and current or past history of mental disorder.
Collapse
Affiliation(s)
- Teresa Bobes-Bascarán
- Department of Psychology (TBB, LGA), Universidad de Oviedo, Oviedo, Spain,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Spain,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain,Servicio de Salud del Principado de Asturias (SESPA) (TBB, PAS, CP, AP, MPGP, JB), Oviedo, Spain
| | - Pilar A Sáiz
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Spain; Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain; Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain; Servicio de Salud del Principado de Asturias (SESPA) (TBB, PAS, CP, AP, MPGP, JB), Oviedo, Spain; Department of Psychiatry (PAS, AV, CMC, LFT, LGA, MPGP, JB), Universidad de Oviedo, Oviedo, Spain.
| | - Angela Velasco
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Spain,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain,Department of Psychiatry (PAS, AV, CMC, LFT, LGA, MPGP, JB), Universidad de Oviedo, Oviedo, Spain
| | - Clara Martínez-Cao
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Spain,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain,Department of Psychiatry (PAS, AV, CMC, LFT, LGA, MPGP, JB), Universidad de Oviedo, Oviedo, Spain
| | - Cristina Pedrosa
- Servicio de Salud del Principado de Asturias (SESPA) (TBB, PAS, CP, AP, MPGP, JB), Oviedo, Spain
| | - Almudena Portilla
- Servicio de Salud del Principado de Asturias (SESPA) (TBB, PAS, CP, AP, MPGP, JB), Oviedo, Spain
| | - Lorena de la Fuente-Tomas
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Spain,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain,Department of Psychiatry (PAS, AV, CMC, LFT, LGA, MPGP, JB), Universidad de Oviedo, Oviedo, Spain
| | - Leticia García-Alvarez
- Department of Psychology (TBB, LGA), Universidad de Oviedo, Oviedo, Spain,Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Spain,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain
| | - María P García-Portilla
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Spain,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain,Servicio de Salud del Principado de Asturias (SESPA) (TBB, PAS, CP, AP, MPGP, JB), Oviedo, Spain,Department of Psychiatry (PAS, AV, CMC, LFT, LGA, MPGP, JB), Universidad de Oviedo, Oviedo, Spain
| | - Julio Bobes
- Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Spain,Instituto de Investigación Sanitaria del Principado de Asturias (ISPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain,Instituto Universitario de Neurociencias del Principado de Asturias (INEUROPA) (TBB, PAS, AV, CMC, LFT, LGA, MPGP, JB), Oviedo, Spain,Servicio de Salud del Principado de Asturias (SESPA) (TBB, PAS, CP, AP, MPGP, JB), Oviedo, Spain,Department of Psychiatry (PAS, AV, CMC, LFT, LGA, MPGP, JB), Universidad de Oviedo, Oviedo, Spain
| |
Collapse
|
9
|
García-Álvarez L, Martínez-Cao C, Bobes-Bascarán T, Portilla A, Courtet P, de la Fuente-Tomás L, Velasco Á, González-Blanco L, Zurrón-Madera P, Fonseca-Pedrero E, Sáiz PA, García-Portilla MP, Bobes J. Validation of a European Spanish-version of the Self-Evaluation of Negative Symptoms (SNS) in patients with schizophrenia. Rev Psiquiatr Salud Ment (Engl Ed) 2020; 15:S1888-9891(20)30036-7. [PMID: 32517967 DOI: 10.1016/j.rpsm.2020.04.011] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2019] [Revised: 04/11/2020] [Accepted: 04/28/2020] [Indexed: 02/03/2023]
Abstract
INTRODUCTION Negative symptoms can be grouped into five domains: apathy/avolition, anhedonia, asociality, alogia, and affective flattening. There are few validate self-rated measures that assess these five dimensions. Therefore, this study aimed to validate the Self-Evaluation of Negative Symptoms (SNS) in Spanish patients with schizophrenia. MATERIAL AND METHODS Cross-sectional, validation study in 104 outpatients with schizophrenia evaluated using the Spanish version of the following scales: Clinical Assessment Interview for Negative Symptoms (CAINS), Positive and Negative Syndrome Scale (PANSS), Clinical Global Impression Scale for Schizophrenia (CGI-SCH), Personal and Social Performance (PSP), Motivation and Pleasure Scale - Self-Report (MAP-SR), 36-item Short-Form Health Survey (SF-36) and the Self-Evaluation of Negative Symptoms (SNS). RESULTS RELIABILITY Internal consistency (Cronbach's alpha) was 0.915. Convergent validity: The Pearson correlation coefficient between MAP-SR and SNS Total scores was 0.660 (p<0.001). For PANSS-N, the correlation was 0.437 (p<0.005) and with the CAINS-Total was 0.478 (p<0.005). Divergent validity: The Pearson correlation coefficient between SNS and PSP was r=-0.372 (p≤0.001), and with SF-36 Physical and Mental Summary Component scores were r=-0.213 (p=0.066) and r=-0.144 (p=0.219), respectively. Discriminant validity: SNS Total scores were significantly statistically different according to the severity of the negative symptomatology rated by the CGI-SCH negative scale (p<0.001). CONCLUSION The SNS is a reliable and valid instrument to self-rate the five domains of negative symptoms in patients with schizophrenia and seems to be appropriate for use in everyday clinical practice as a complementary measure to the evaluation performed by the clinician.
Collapse
Affiliation(s)
- Leticia García-Álvarez
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain
| | - Clara Martínez-Cao
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain
| | - Teresa Bobes-Bascarán
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain
| | - Almudena Portilla
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain
| | | | - Lorena de la Fuente-Tomás
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain
| | - Ángela Velasco
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain
| | - Leticia González-Blanco
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain
| | - Paula Zurrón-Madera
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain
| | - Eduardo Fonseca-Pedrero
- Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Departamento Ciencias de la Educación, Universidad de la Rioja, Longroño, Spain
| | - Pilar A Sáiz
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain
| | - María Paz García-Portilla
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain.
| | - Julio Bobes
- Departamento de Psiquiatría, University of Oviedo, Oviedo, Spain; Institute of Health Research of Principado de Asturias (ISPA), Oviedo, Spain; Institute of Neurosciences of Principado de Asturias (INEUROPA), Oviedo, Spain; Centre for Biomedical Research in Mental Health (CIBERSAM), Spain; Health Service of Principado de Asturias (SESPA), Oviedo, Spain
| |
Collapse
|
10
|
Martínez-Cao C, García-Álvarez L, Bobes-Bascarán T, de la Fuente-Tomás L, Fernández-Egea E, Velasco Á, González-Blanco L, Zurrón-Madera P, Fonseca-Pedrero E, Sáiz-Martínez PA, García-Portilla MP, Bobes J. Validation of a European Spanish adaptation of the Apathy Evaluation Scale-self-rated version (AES-S) in patients with schizophrenia. Rev Psiquiatr Salud Ment (Engl Ed) 2020; 15:S1888-9891(20)30033-1. [PMID: 32507728 DOI: 10.1016/j.rpsm.2020.04.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2019] [Revised: 04/10/2020] [Accepted: 04/16/2020] [Indexed: 12/20/2022]
Abstract
INTRODUCTION Apathy is a negative symptom of schizophrenia and is associated with poor real world functioning. Therefore, it is important to have validated psychometric instruments to assess this symptom. This is the first study to validate the Spanish adaptation of the self-rated version of the Apathy Assessment Scale (AES-S) in patients with schizophrenia. MATERIALS AND METHODS Naturalistic, cross-sectional, validation study in 104 patients with schizophrenia evaluated using the following scales: Clinical Global Impression-Severity (CGI-S), Personal and Social Performance (PSP), Clinical Assessment Interview for Negative Symptoms (CAINS), Self-report of Negative Symptoms (SNS), Motivation and Pleasure Scale-Self-Report (MAP-SR), Calgary Depression Scale for Schizophrenia (CDSS), and Apathy Evaluation Scale-self-rated version (AES-S). RESULTS Reliability: Internal consistency (Cronbach's alpha) was 0.908. Convergent validity: The Pearson correlation coefficient between AES-S and CAINS-MAP total scores was -0.483 (p<0.001). For SNS, total and avolition subscale scores were -0.803 and -0.639 (p<0.001), respectively. With the MAP-SR, the correlation coefficient was -0.727 (p<0.001). Divergent validity: The Pearson correlation coefficient between AES-S and PSP total scores was 0.504 (p<0.001). Furthermore, with the CDSS, the correlation coefficient was -0.431 (p<0.001). Discriminant validity: The AES-S discriminated between different levels of illness severity according to CGI-S scores. Factor analysis: A three-component solution explained 57.32% of the variance. Pearson correlations between coefficients were 1-2=0.265, 1-3=0.464, and 2-3=0.060. CONCLUSION The Spanish AES-S is a reliable and valid instrument for assessing apathy in Spanish patients with schizophrenia. It seems to be appropriate for use in everyday clinical practice as a means of monitoring apathy in these patients.
Collapse
Affiliation(s)
| | | | | | | | | | - Ángela Velasco
- Dpto. Psiquiatría, CIBERSAM, Universidad de Oviedo, Oviedo, Spain
| | | | | | | | | | | | - Julio Bobes
- Dpto. Psiquiatría, CIBERSAM, ISPA, Universidad de Oviedo, Oviedo, Spain
| |
Collapse
|